CODA, NCT04910711: Investigating the Interaction Between Two Long-acting Reversible Methods of Contraception and Dolutegravir, a Treatment for HIV |
|
|
| Active, not recruiting | 4 | 140 | RoW | Dolutegravir, Levonorgestrel implant, Depo medroxyprogesterone acetate injection | Botswana Harvard AIDS Institute Partnership, University of Liverpool | Human Immunodeficiency Virus, Contraception, ART | 08/23 | 10/24 | | |
| Recruiting | N/A | 700 | RoW | Cabotegravir/ Rilpivirine, Etonogestrel (ETG) implant, Intramuscular depo-medroxyprogesterone acetate (IM DMPA), Levonorgestrel, NNRTI, PI, or INSTI-containing 1st or 2nd line ART regimens | University of Alabama at Birmingham, Moi Teaching and Referral Hospital, Indiana University, University of Nebraska, National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections, Contraception, Drug-drug Interaction | 03/25 | 03/25 | | |
